Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study.
Briceño J, Cruz-Ramírez M, Prieto M, Navasa M, Ortiz de Urbina J, Orti R, Gómez-Bravo MÁ, Otero A, Varo E, Tomé S, Clemente G, Bañares R, Bárcena R, Cuervas-Mons V, Solórzano G, Vinaixa C, Rubín A, Colmenero J, Valdivieso A, Ciria R, Hervás-Martínez C, de la Mata M. Briceño J, et al. Among authors: barcena r. J Hepatol. 2014 Nov;61(5):1020-8. doi: 10.1016/j.jhep.2014.05.039. Epub 2014 Jun 4. J Hepatol. 2014. PMID: 24905493 Clinical Trial.
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Castells L, Rimola A, Manzardo C, Valdivieso A, Montero JL, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, González-García J, Esteban-Mur JI, Miro JM; FIPSE LT-HIV Investigators. Castells L, et al. Among authors: barcena r. J Hepatol. 2015 Jan;62(1):92-100. doi: 10.1016/j.jhep.2014.07.034. Epub 2014 Aug 13. J Hepatol. 2015. PMID: 25127748
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.
Agüero F, Forner A, Manzardo C, Valdivieso A, Blanes M, Barcena R, Rafecas A, Castells L, Abradelo M, Torre-Cisneros J, Gonzalez-Dieguez L, Salcedo M, Serrano T, Jimenez-Perez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators. Agüero F, et al. Among authors: barcena r. Hepatology. 2016 Feb;63(2):488-98. doi: 10.1002/hep.28321. Epub 2016 Jan 4. Hepatology. 2016. PMID: 26516761
Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study.
Agüero F, Forner A, Valdivieso A, Blanes M, Barcena R, Manzardo C, Rafecas A, Castells L, Abradelo M, Barrera-Baena P, González-Diéguez L, Salcedo M, Serrano T, Jiménez-Pérez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators. Agüero F, et al. Among authors: barcena r. Liver Transpl. 2017 May;23(5):645-651. doi: 10.1002/lt.24741. Liver Transpl. 2017. PMID: 28188668 Free article.
Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
Bárcena R, Del Campo S, Moraleda G, Casanovas T, Prieto M, Buti M, Moreno JM, Cuervas V, Fraga E, De la Mata M, Otero A, Delgado M, Loinaz C, Barrios C, Dieguez ML, Mas A, Sousa JM, Herrero JI, Muñoz R, Avilés JF, Gonzalez A, Rueda M. Bárcena R, et al. Transplant Proc. 2005 Nov;37(9):3960-2. doi: 10.1016/j.transproceed.2005.10.061. Transplant Proc. 2005. PMID: 16386596
Late orthotopic liver retransplant: indications and survival. Liver Transplant Spanish Group.
Clemente G, Durán F, Loinaz C, Casanovas T, Rímola A, Jara P, Cuervas Mons V, Pons JA, Margarit C, Prieto M, de la Mata M, Bárcena R, Casafont F, Suarez F, Quiroga JA, Varo E, González A, Maldonado J, Suarez MJ. Clemente G, et al. Among authors: barcena r. Transplant Proc. 1999 Feb-Mar;31(1-2):511-4. doi: 10.1016/s0041-1345(98)01732-1. Transplant Proc. 1999. PMID: 10083214 No abstract available.
Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin.
Oton E, Barcena R, Moreno-Planas JM, Cuervas-Mons V, Moreno-Zamora A, Barrios C, Garcia-Garzon S, Moreno A, Boullosa-Graña E, Rubio-Gonzalez EE, Garcia-Gonzalez M, Blesa C, Mateos ML. Oton E, et al. Among authors: barcena r. Am J Transplant. 2006 Oct;6(10):2348-55. doi: 10.1111/j.1600-6143.2006.01470.x. Epub 2006 Jul 26. Am J Transplant. 2006. PMID: 16869810 Free article.
Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.
Bárcena R, Moreno A, Rodríguez-Gandía MA, Albillos A, Arocena C, Blesa C, García-Hoz F, Graus J, Nuño J, López-Hervás P, Gajate L, Martínez A, Bermejo T, Mateos ML, Del Campo S; Hospital Ramón y Cajal Liver Transplant Group. Bárcena R, et al. J Hepatol. 2013 Mar;58(3):421-6. doi: 10.1016/j.jhep.2012.10.009. Epub 2012 Oct 13. J Hepatol. 2013. PMID: 23073223
HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.
Moreno A, Bárcena R, García-Garzón S, Muriel A, Quereda C, Moreno L, Mateos ML, Fortún J, Martín-Dávila P, García M, Blesa C, Otón E, Moreno A, Moreno S. Moreno A, et al. Among authors: barcena r. J Hepatol. 2005 Nov;43(5):783-90. doi: 10.1016/j.jhep.2005.05.019. Epub 2005 Jun 21. J Hepatol. 2005. PMID: 16084622
144 results